Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046761 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
A Phase 2 study, sponsored by Ono Pharma USA.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1,320
- Enrollment target
NCT00046761: Clinical Trial Phase 2 study, sponsored by Ono Pharma USA.
NCT00046761 is a Phase 2 study that was terminated before completion, run by Ono Pharma USA. The registered enrollment target is 1,320 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (892% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00046761, a Phase 2 study, was terminated before completion, sponsored by Ono Pharma USA.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1,320 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the efficacy of ONO-2506 versus placebo in neurological stroke outcome in patients with acute ischemic stroke.
Interventions
- DRUG ONO-2506
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,320 participants |
| Start Date | 2002-11 |
| Phase | Phase 2 |
Why NCT00046761 stopped before completion
NCT00046761 is an interventional study that assigns participants to a tested intervention. Its 1,320 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (892% higher).
The record links to 0 conditions, and to 1 intervention - of which ONO-2506 is the first listed.
NCT00046761 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00046761 about?
NCT00046761 is a clinical study titled "A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke". The primary objective of this study is to compare the efficacy of ONO-2506 versus placebo in neurological stroke outcome in patients with acute ischemic stroke.
What is the current status of trial NCT00046761?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1,320 participants. The study started on 2002-11.
What interventions are being tested in trial NCT00046761?
The interventions under investigation include: ONO-2506 (DRUG).
Who is sponsoring clinical trial NCT00046761?
This trial is sponsored by Ono Pharma USA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00046761's enrollment target sits among peer trials
1,320 13th of 2000 higher than 1,988 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06557005 · 1,320 participants · NA
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
- NCT07213908 · 1,320 participants · NA
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
- NCT07144800 · 1,319 participants · NA
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
- NCT05097287 · 1,324 participants · Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia